[The place of syringe exchange programs in reducing harm in Canadian prisoners].
The prevalence rates of illicit drug consumption within the prison system are much higher than those in the Canadian population in general. Of the substances used in detention, those of most concern to prison and public health authorities are injection drugs, as the sharing of injection drug equipment may be responsible for the high prevalence of blood-borne diseases in prison facilities. Faced with this situation, the Correctional Service of Canada put in practice a number of harm reduction strategies targeting injection drug users, such as methadone maintenance programs and access to bleach. However, despite their use in the community, needle-exchange programs are not yet allowed in penitentiaries. This article analyzes the limits of harm reduction strategies approved by the prison authorities and discusses the sources of resistance that continue to impede the realization of a pilot project to assess the feasibility of needle-exchange programs in detention in Canada.
Orsi
Mylène M
MM
Ecole de criminologie de l'Université de Montréal, Centre international de criminologie comparée, Recherche et intervention sur les substances psychoactives Québec (RISQ), Montréal, Québec. mylene.magrinelli@umontreal.ca
Brochu
Serge
S
D017848:Blood-Borne Pathogens; D002170:Canada; D004203:Disinfection; D055030:Drug Users / Q000523:psychology / Q000706:statistics & numerical data*; D004866:Equipment Contamination / Q000517:prevention & control*; D005240:Feasibility Studies; D040261:Harm Reduction; D006801:Humans; D008691:Methadone / Q000627:therapeutic use*; D018671:Needle-Exchange Programs / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data; D009339:Needles / Q000382:microbiology; D011329:Prisoners / Q000523:psychology / Q000706:statistics & numerical data*; D011330:Prisons / Q000331:legislation & jurisprudence*; D015397:Program Evaluation; D015819:Substance Abuse, Intravenous / Q000453:epidemiology* / Q000534:rehabilitation*
D008691:Methadone